Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.9500 (-1.14%) ($6.9500 - $6.9500) on Wed. Feb. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.93% (three month average) | RSI | 61 | Latest Price | $6.9500(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -2.6% a day on average for past five trading days. | Weekly Trend | CEMI advances 2.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) XLC(-36%) UNG(-14%) VXX(10%) XBI(-29%) XAR(-55%) | Factors Impacting CEMI price | CEMI will decline at least -2.465% in a week (0% probabilities). XRT(-21%) ICLN(-44%) IDRV(-31%) IPO(-65%) INDA(-54%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.465% (StdDev 4.93%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.06 | 5 Day Moving Average | $7.26(-4.27%) | 10 Day Moving Average | $7.44(-6.59%) | 20 Day Moving Average | $7.06(-1.56%) | To recent high | -12.4% | To recent low | 38% | Market Cap | $140m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |